Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-24 @ 10:53 PM
NCT ID:
NCT03255369
Eligibility Criteria:
Inclusion Criteria:
The study population will be composed of pregnant women who present symptoms compatible with ZIKAV infection, with skin rash, arthralgia-associated fever, myalgia, non-purulent conjunctivitis, or headache and asymptomatic pregnant women identified at the same time of possibility of exposure. We will include patients with RT- PCR positive.
All pregnant women who are in the prenatal follow up at IFF and CSGSF, irrespective of the gestational age, are elegible as a not exposed in the beginning.
Children born during the outbreak by mothers with confirmed infection, suspected infection and normal pregnancy
Exclusion Criteria:
Pregnant women with chromosomal abnormalities detected during fetal life or birth will be excluded.
\-
Sex:
ALL
Minimum Age:
2 Days
Maximum Age:
3 Years
Study:
NCT03255369
Study Brief:
Protocol Section:
NCT03255369